Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer

por Luo, Lixi, Wei, Qun, Xu, Chenpu, Dong, Minjun, Zhao, Wenhe
Publicado 2022

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein/Albumin Ratio in Luminal Breast Cancers With HER2-Negativity

por Chen, Fei, Chen, Danzhi, Jin, Lidan, Xu, Chenpu, Zhao, Wenhe, Hu, Wenxian
Publicado 2022

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer

por Hu, Wenxian, Lv, Kezhen, Teng, Rongyue, Chen, Jida, Xu, Chenpu, Jin, Lidan, Chen, Yongxia, Zhao, Wenhe
Publicado 2021

Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review)

por ZHOU, JICHUN, TENG, RONGYUE, WANG, QINCHUAN, XU, CHENPU, GUO, JUFENG, YUAN, CHAO, SHEN, JIANGUO, HU, WENXIAN, WANG, LINBO, XIE, SHUDUO
Publicado 2013

PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer

por Chen, Yongxia, Jia, Yunlu, Mao, Misha, Gu, Yifeng, Xu, Chenpu, Yang, Jingjing, Hu, Wenxian, Shen, Jun, Hu, Dengdi, Chen, Cong, Li, Zhaoqing, Chen, Lini, Ruan, Jian, Shen, Peng, Zhou, Jichun, Wei, Qun, Wang, Linbo
Publicado 2021